August 18, 2022
European Commission approves Oncopeptides’ Pepaxti for the treatment of patients with relapsed refractory multiple myeloma
Media
August 18, 2022
Targovax ASA: Second quarter and first half year 2022 results
August 17, 2022
Vicore IPF interim data selected as an oral “late-breaker” at the ERS congress
August 11, 2022
Aprea Therapeutics Reports Second Quarter 2022 Financial Results and Provides Update on Business Operations
August 11, 2022
Oncopeptides publishes Q2 report 2022
August 11, 2022
Targovax ASA: Invitation to Targovax’s second quarter and first half 2022 presentation, Thursday 18 August
August 10, 2022
Aro Biotherapeutics Receives FDA Orphan Drug Designation for ABX1100 for the Treatment of Pompe Disease
August 10, 2022
Spruce Biosciences Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 09, 2022
Fusion Pharmaceuticals Announces Second Quarter 2022 Financial Results And Clinical Program Updates
August 03, 2022
Pulmonx Reports Second Quarter 2022 Financial Results